Original articles

Effect of Jiedu Huayu decoction (解毒化瘀汤) on oral mucosal Axin and β-catenin expression in oral submucosal fibrosis model rats

  • Xuan ZHU ,
  • An LOU ,
  • Keke ZHU ,
  • Mingyu RUAN
Expand
  • 1 Department of Science and Technology, Hunan University of Chinese Medicine, Changsha 410208, China
    2 Department of prosthodontics, Hunan University of Chinese Medicine Affiliated Dental Hospital, Changsha 410005, China
    3 Department of Stomatology, the First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha 410021, China
    4 School of Medicine, Hunan University of Chinese Medicine, Changsha 410208, China

Received date: 2023-01-11

  Accepted date: 2023-07-22

  Online published: 2024-06-17

Supported by

Scientific Research Project of Hunan Provincial Education Department: to Investigate the Mechanism of Blood-activating Circulation Through the Regulation of Blood Stasis and Detoxification based on Wnt β-catenin Signaling Pathway(21B0398);Study on the Epithelial Mesenchymal Transformation of Human Umbilical Vein Endothelial Cells Induced by Fuxin Formula(22C0190);Changsha City 2020 Annual Guiding Science and Technology Plan Projects: Effect of Blood Circulation and Detoxification Method on Epithelial Barrier Composition and Function of Oral Mucosa(kzd2001010)

Abstract

OBJECTIVE: To investigate the protective effect of the Chinese herbal formula of Jiedu Huayu decoction (解毒化瘀汤, JHD) on oral mucosa of rats with oral submucosal fibrosis (OSF) and its potential mechanism of action.

METHODS: Sprague-Dawley male OSF model rats were constructed by injection of betaine and topical rubbing and were randomly grouped and administered by gavage for 4 weeks. Mouth opening and buccal mucosa scores interleukin levels and the expression of Axin and β-catenin proteins or genes were measured before and after drug administration.

RESULTS: After treatment with JHD the buccal mucosal lesions of rats were significantly reduced Axin protein and mRNA expression were significantly increased β-catenin protein and mRNA expression were significantly decreased interleukin-1β and interleukin-6 levels were decreased and interleukin-10 levels were increased.

CONCLUSION: The mechanism of action of JHD can effectively alleviate the pathological damage of buccal mucosa in OSF rats which may be related to the promotion of Axin expression and inhibition of β-catenin expression.

Cite this article

Xuan ZHU , An LOU , Keke ZHU , Mingyu RUAN . Effect of Jiedu Huayu decoction (解毒化瘀汤) on oral mucosal Axin and β-catenin expression in oral submucosal fibrosis model rats[J]. Journal of Traditional Chinese Medicine, 2024 , 44(4) : 688 -693 . DOI: 10.19852/j.cnki.jtcm.20240617.001

References

1. Cai H, Song LW. Clinical observation on the treatment of oral submucosa fibrosis with Glycyrrhiza glabra combined with Si Miao Yong An Tang plusreduction. Zhong Hua Zhong Yi Yao Xue Kang 2016; 34: 1486-8.
2. Jian XC, Gao X. Etiology pathogenesis diagnosis and treatment of oral submucosal fibrous lesions. Kou Qiang Ji Bing Fang Zhi 2021; 29: 217-25.
3. Peng Q, Li HY, Chen J, et al. Oral submucous fibrosis in Asian countries. J Oral Pathol Med 2020; 49: 294-304.
4. Arakeri G, Patil SG, Aljabab AS, et al. Oral submucous fibrosis: an update on pathophysiology of malignant transformation. J Oral Pathol Med 2017; 46: 413-7.
5. Shih YH, Wang TH, Shieh TM, et al. Oral submucous fibrosis: a review on etiopathogenesis diagnosis and therapy. Int J Mol Sci 2019; 20: 2940.
6. Chowdhury P, Nagamalini BR, Singh J, et al. Expressionof β-catenin in oral leukoplakia and oral submucous fibrosis: an immunohistochemical study. J Oral Maxillofac Pathol 2021; 25: 124-30.
7. Katase N, Lefeuvre M, Tsujigiwa H, et al. Knockdown of Dkk-3 decreasescancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma-derived cells. Oncol Rep 2013; 29: 1349-55.
8. Zhang L, Tan J, Liu YP, et al. Effects of curcumin extract on TGF-β_1 IL-1 and Bcl-2 in OSF model rats and related mechanisms. Yi Nan Bing Za Zhi 2021; 20: 1152-6.
9. Adhikari S, Rimal J, Maharjan IK, et al. Efficacy of curcumin in combination with intralesional dexamethasone with hyaluronidase in the treatment of oral submucous fibrosis: a randomized controlled trial. Asian Pac J Cancer Prev 2022; 23: 3125-32.
10. Muller S, Tilakaratne WM. Update from the 5th edition of the world health organization classification of head and neck tumors: tumours of the oral cavity and mobile tongue. Head Neck Pathol 2022; 16: 54-62.
11. Yang B, Fu MF, Tang ZG. Construction of a rat oral submucosal fibrosismodel by betaine and mechanical stimulation. Hua Xi Kou Qiang Yi Xue Za Zhi 2019; 37: 260-4.
12. Shetty SS, Sharma M, Fonseca FP, et al. Signaling pathways promoting epithelial mesenchymal transition in oral submucous fibrosis and oral squamous cell carcinoma. Jpn Dent Sci Rev 2020; 56: 97-108.
13. He Y, Jianng X. The role of epithelial-mesenchymal transition in oralsquamous cell carcinoma and oral submucous fibrosis. Clin Chim Acta 2007; 383: 51-6.
14. Ge WS, Wang YJ, Wu JX, et al. β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation. Mol Med Rep 2014; 9: 2145-51.
15. Bai Y, Sha J, Kanno T. The role of carcinogenesis-related biomarkers in the wnt pathway and their effects on Epithelial-Mesenchymal Transition (EMT) in oral squamous cell carcinoma. Cancers (Basel) 2020; 12: 555.
16. Ji L, Lu B, Zamponi R, et al. USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin. Nat Commun 2019; 10: 4184.
17. Li YC, Tan J, Chen A, et al. Effect of Dan Xuan Kou Kang on TGFβ expression in rats with oral submucosa fibrosis. Xin Zhong Yi 2006; 38: 89-91.
18. Tan J, Chen A. Clinical observation on the treatment of oral submucosal fibrosis with blood activation and fibrillation formula. Zhong Guo Zhong Yi Yao Xin Xi Za Zhi 2001; 8: 71-2.
19. Yu Y. Clinical observation on the treatment of oral lichen planus with detoxifying and stasis-removing herbs combined with tretinoin oral ointment. Zhong Guo Zhong Yi Yao Xian Dai Yuan Cheng Jiao Yu 2021; 19: 136-7.
Outlines

/